Ruttenberg Cancer Center, Mount Sinai Hospital — New York, New York

Ruttenberg Cancer Center, Mount Sinai Hospital is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ruttenberg Cancer Center, Mount Sinai Hospital has participated in 1 clinical trials.

Therapeutic areas: Biliary Tract Cancer.

Sponsors: ASLAN Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ruttenberg Cancer Center, Mount Sinai Hospital?

Ruttenberg Cancer Center, Mount Sinai Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ruttenberg Cancer Center, Mount Sinai Hospital conducted?

Ruttenberg Cancer Center, Mount Sinai Hospital has 1 clinical trials on record. Their work covers Biliary Tract Cancer.

Is Ruttenberg Cancer Center, Mount Sinai Hospital accredited by Crixeo Health?

Ruttenberg Cancer Center, Mount Sinai Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ruttenberg Cancer Center, Mount Sinai Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.